4//SEC Filing
Weiss Amir 4
Accession 0000950170-25-035542
CIK 0000818686other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:29 PM ET
Size
9.6 KB
Accession
0000950170-25-035542
Insider Transaction Report
Form 4
Weiss Amir
Chief Accounting Officer
Transactions
- Exercise/Conversion
Restricted Share Units
2025-03-05−3,566→ 0 total→ Ordinary Shares (3,566 underlying) - Award
Restricted Share Units
2025-03-05+14,150→ 14,150 total→ Ordinary Shares (14,150 underlying) - Exercise/Conversion
Ordinary Shares
2025-03-05+3,566→ 30,250 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 5, 2021, with 3,564 vested on each of March 5, 2022, March 5, 2023 and March 5, 2024, and 3,566 vested on March 5, 2025.
- [F4]Restricted share units were granted on March 5, 2025, with 3,537 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 3,539 vesting on March 5, 2029.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001897057
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:29 PM ET
- Size
- 9.6 KB